Vin Milano Retains Pennsylvania Bio Leadership Role


Vin Milano, vice chairman of Pennsylvania Bio, has been named CEO of Idera Pharmaceuticals of Cambridge, Ma.

Milano, whose main office will remain in Exton, will keep his leadership role with Pennsylvania Bio as hePABio_eps_logo also leads Idera from Cambridge.

Idera is a clinical stage biotechnology company with expertise in discovering, developing and commercializing novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. Idera is focused on harnessing the potential of its proprietary technology to treat genetically defined forms of B-cell lymphomas and rare autoimmune diseases.

Pennsylvania Bio, founded 25 years ago by a group of Biotech CEOs, represents  medical device companies, pharmaceutical companies, investment organizations, academic institutions, and a myriad of service industries that support the life sciences in Pennsylvania. Its offers public policy clout and strategic connections to advance the life sciences industry.

John George of the Philadelphia Business Journal recently reported on Milano’s plans here.



Connect With Your Community

Subscribe to stay informed!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.